Legislation
- Title
- Health – Drug Cost Commission
- Sponsored by
- Delegates Pena-Melnyk, Ali, Anderson, Atterbeary, B. Barnes, D. Barnes, Barron, Barve, Beidle, Branch, Brooks, Carey, Carr, Chang, Clippinger, Conaway, Cullison, Davis, Dumais, Ebersole, Fennell, Fraser-Hidalgo, Frush, Gaines, Gibson, Gilchrist, Glenn, Gutierrez, Hayes, Haynes, Healey, Hettleman, Hill, Hixson, C. Howard, Impallaria, Jackson, Jalisi, Jones, Kaiser, Kelly, Kramer, Lafferty, Lam, J. Lewis, R. Lewis, Lierman, Luedtke, McDonough, McIntosh, A. Miller, Moon, Morales, Morhaim, Mosby, Patterson, Platt, Proctor, Queen, Reznik, Robinson, Rosenberg, Sample-Hughes, Sanchez, Stein, Sydnor, Tarlau, Turner, Valderrama, Valentino-Smith, Vallario, Waldstreicher, Walker, A. Washington, M. Washington, Wilkins, Wilson, K. Young, P. Young, Pendergrass, Bromwell, Kipke, Krebs, Metzgar, Miele, Morgan, Saab, Szeliga, and West
- Status
- In the Senate - Favorable Report by Finance
- Analysis
- Fiscal and Policy Note (Revised)
Synopsis
Establishing the Drug Cost Commission to determine how to make prescription drugs more affordable for State residents, State and local government, commercial health plans and other stakeholders within the State; requiring the Commission to create an advisory council; requiring the Commission to provide public notice of each meeting, make certain materials available to the public and provide an opportunity for public comment; requiring the Commission to report its findings and recommendations by January 1, 2019; etc.
Committees
Details
Cross-filed with: SB1023
Bill File Type: Regular
Effective Date(s): June 1, 2018
Bill imposes a mandated appropriation in the annual State Budget Bill
Creates a Task Force or Commission
History
Toggle History Dropdown
File Code
Toggle Filecode Dropdown
Subjects
Toggle Subjects Dropdown
Statutes
Last Updated: 2/3/2020 2:32 PM